We are live on ! Find out more
AAM

Alpine Associates Management Portfolio holdings

AUM $1.6B
1-Year Est. Return 93.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+93.19%
3 Year Est. Return
+366.27%
5 Year Est. Return
+1,301.74%
10 Year Est. Return
+22,525.34%
AUM
$1.91B
AUM Growth
+$261M
Cap. Flow
+$171M
Cap. Flow %
8.96%
Top 10 Hldgs %
58%
Holding
66
New
23
Increased
14
Reduced
7
Closed
21

Sector Composition

Rank Sector Weight
1 Energy 18.23%
2 Healthcare 14.79%
3 Industrials 14.2%
4 Technology 13.67%
5 Financials 13.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTM
51
DELISTED
Arcadium Lithium plc
ALTM
-5,942,930
Closed -$30.5M
ALTM
52
PUT
DELISTED
Arcadium Lithium plc
ALTM
-527,800
Closed -$2.71M
INFN
53
DELISTED
Infinera Corporation Common Stock
INFN
-1,984,500
Closed -$14M
MTTR
54
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
-2,239,182
Closed -$10.6M
HCP
55
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
-2,394,854
Closed -$81.9M
SILV
56
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-3,393,753
Closed -$30.9M
ROIC
57
DELISTED
Retail Opportunity Investments Corp.
ROIC
-1,350,000
Closed -$23.4M
SUM
58
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
-468,500
Closed -$23.7M
RVNC
59
DELISTED
Revance Therapeutics, Inc.
RVNC
-2,349,966
Closed -$7.14M
CDMO
60
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-1,946,082
Closed -$24M
SCWX
61
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
-623,254
Closed -$5.27M
B
62
DELISTED
Barnes Group Inc.
B
-412,414
Closed -$19.5M
SMAR
63
DELISTED
Smartsheet Inc.
SMAR
-591,400
Closed -$33.1M
GATO
64
DELISTED
Gatos Silver, Inc.
GATO
-2,279,155
Closed -$31.9M
PSTX
65
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-2,016,700
Closed -$19.4M
ARCH
66
DELISTED
Arch Resources, Inc.
ARCH
-112,569
Closed -$15.9M

Similar funds

Alpine Associates Management's Q1 2025 Portfolio in Review

As of Q1 2025, Alpine Associates Management held 66 positions worth $1.91B, up 16% from $1.65B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Alpine Associates Management deployed $171M of net new capital in Q1 2025, opening 23 new positions and adding to 14 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 719,500 shares worth $94.9M.

By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Juniper Networks, an estimated $57.5M trimmed.

  • Alpine Associates Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 719,500 shares worth $94.9M.
  • Alpine Associates Management added most to Kellanova in Q1 2025, an estimated $44.8M increase.
  • Alpine Associates Management's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $57.5M.
  • Alpine Associates Management fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $81.9M.
  • Alpine Associates Management's ten largest holdings make up 58% of its $1.91B portfolio in Q1 2025.
  • Alpine Associates Management opened 23 new positions and closed 21 in Q1 2025.
  • Alpine Associates Management's portfolio value rose 16% quarter-over-quarter to $1.91B.

Based on Alpine Associates Management's 13F filing for Q1 2025, filed 8 May 2025.